ProLogium and TDAC sign non‑binding term sheets for up to $135 million of PIPE investment

ProLogium Holding Inc. and the SPAC Translational Development Acquisition Corp. (TDAC) announced that existing and strategic investors have signed non‑binding term sheets to invest up to $135 million at $10.00 per share concurrent with the closing of their business combination. The proceeds are earmarked for the build‑out of ProLogium’s gigafactory in Dunkirk, France and for expansion into new market applications. The transaction is slated to close in December 2026, subject to shareholder approval and customary closing conditions.

The investment will provide capital to advance ProLogium’s French gigafactory, potentially accelerating production capacity and revenue growth. Upon completion, ProLogium will list on Nasdaq under the ticker PRLG, while TDAC will complete its merger, affecting both securities.

  • 1Non‑binding term sheets were signed for up to $135 million of investment.
  • 2Investments will be made in common shares at $10.00 per share.
  • 3ProLogium expects to use the proceeds to build out its gigafactory in Dunkirk, France.
  • 4The business combination is expected to close in December 2026, subject to shareholder approval.
  • 5ProLogium will list on Nasdaq under the ticker symbol PRLG after the transaction.
  • 6TDAC is the SPAC partner in the transaction and will merge with ProLogium.
  • Two materials report different total investment amounts: $85 million versus $135 million.

Sources